#24 - Tom Dayspring, M.D., FACP, FNLA – Part V of V: Lp(a), inflammation, oxLDL, remnants, and more
The Peter Attia Drive
00:00
Is It Going to Be a Positive Trial?
The company that developed the product is not brought to market. But i think they're going to. Because this november, at the american hot association, you are going to get the people at risk who are on statons and half of em are getting statons plus e p a. And we're going to get alcom wagos of e p a - it's hit. It's three, four gms. So are we going to see carty vascular? All indications, and we're all optimists. Even e i me world will get to the bottom of this. There's no parma grade d h a. Doyou. No, no, no
Transcript
Play full episode
